Evidence map›Paper›PMID 39451366›Full record

ArticleBioengineering (Basel, Switzerland)2024

Adaptive vs. Conventional Deep Brain Stimulation: One-Year Subthalamic Recordings and Clinical Monitoring in a Patient with Parkinson's Disease.

Laura Caffi, Luigi M Romito, Chiara Palmisano, Vanessa Aloia, Mattia Arlotti, Lorenzo Rossi, Sara Marceglia, Alberto Priori, Roberto Eleopra, Vincenzo Levi and 2 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Advanced Therapeutics in Parkinson's Disease: What's New?Current neurology and neuroscience reports · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Laura CaffiParkinson Institute of Milan, ASST G.Pini-CTO, 20126 Milano, Italy.ORCID 0009-0007-2657-5530
Luigi M RomitoParkinson and Movement Disorders Unit, Foundation IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, Italy.ORCID 0000-0002-6772-1035
Chiara PalmisanoParkinson Institute of Milan, ASST G.Pini-CTO, 20126 Milano, Italy.
Vanessa AloiaNewronika S.p.A., 20093 Milano, Italy.
Mattia ArlottiNewronika S.p.A., 20093 Milano, Italy.
Lorenzo RossiNewronika S.p.A., 20093 Milano, Italy.
Sara MarcegliaDepartment of Engineering and Architecture, University of Trieste, 34127 Trieste, Italy.ORCID 0000-0002-0456-866X
Alberto PrioriDepartment of Health Sciences, Aldo Ravelli Research Center for Neurotechnology and Experimental Neurotherapeutics, University of Milan, 20122 Milano, Italy.ORCID 0000-0002-1549-3851
Roberto EleopraParkinson and Movement Disorders Unit, Foundation IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, Italy.
Vincenzo LeviFunctional Neurosurgery Unit, Foundation IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, Italy.
Alberto MazzoniThe BioRobotics Institute, Sant'Anna School of Advanced Studies, 56025 Pisa, Italy.
Ioannis U IsaiasParkinson Institute of Milan, ASST G.Pini-CTO, 20126 Milano, Italy.ORCID 0000-0002-3552-5144

Funding

Deutsche Forschungsgemeinschaft Project-ID 424778381 - TRR 295European Union Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of bio-medical research in the NHSGrigioni Foundation for Parkinson's diseaseItalian Ministry of Research NRRP "Fit4MedRob - Fit for Medical Robotics" Grant (# PNC0000007).New York University School of MedicineThe Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders
6 · The paper itself

Abstract

Conventional DBS (cDBS) for Parkinson's disease uses constant, predefined stimulation parameters, while the currently available adaptive DBS (aDBS) provides the possibility of adjusting current amplitude with respect to subthalamic activity in the beta band (13-30 Hz). This preliminary study on one patient aims to describe how these two stimulation modes affect basal ganglia dynamics and, thus, behavior in the long term. We collected clinical data (UPDRS-III and -IV) and subthalamic recordings of one patient with Parkinson's disease treated for one year with aDBS, alternated with short intervals of cDBS. Moreover, after nine months, the patient discontinued all dopaminergic drugs while keeping aDBS. Clinical benefits of aDBS were superior to those of cDBS, both with and without medications. This improvement was paralleled by larger daily fluctuations of subthalamic beta activity. Moreover, with aDBS, subthalamic beta activity decreased during asleep with respect to awake hours, while it remained stable in cDBS. These preliminary data suggest that aDBS might be more effective than cDBS in preserving the functional role of daily beta fluctuations, thus leading to superior clinical benefit. Our results open new perspectives for a restorative brain network effect of aDBS as a more physiological, bidirectional, brain-computer interface.

Indexed as

adaptive deep brain stimulationbiomarkerslocal field potentialsneuromodulationparkinson’s diseasesubthalamic nucleus

Identifiers

PMID39451366
PMCPMC11504236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.